Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2001
10/31/2001EP1149093A1 4-aryloxindoles as inhibitors of jnk protein kinases
10/31/2001EP1149092A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP1148878A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors
10/31/2001EP1148877A1 Methods for inhibiting bone resorption
10/31/2001EP1148783A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors
10/31/2001EP1108720A9 Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines
10/31/2001EP0754180B1 Anti-helicobacter ester and carbamate derivatives of azolones
10/31/2001CN1320123A Disubstituted maleimide compounds and medicinal utilization thereof
10/31/2001CN1320122A Pyrazole derivatives and salts thereof
10/31/2001CN1320037A Antiviral indoleoxoacetyl piperazine derivatives
10/31/2001CN1319594A Diazesuberane derivant or its salt
10/31/2001CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same
10/30/2001US6310215 Pyrazolone compounds and ophthalmic plastic lens using the same
10/30/2001US6310079 Non-steroidal antiinflammatory agents
10/30/2001US6310068 Benzonitriles and benzofluorides
10/30/2001US6310067 Urocanic acid derivatives
10/30/2001US6310066 1-(4-chloro-phenoxy)-3-(4-(1h-indol-4-yl)-piperazin-1-yl)-propan-2-ol for example
10/30/2001US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/30/2001US6310058 Antimycobacterial agents
10/30/2001US6310057 α-ketoamide multicatalytic protease inhibitors
10/30/2001CA2113189C Diaminic compounds, preparation, use and intermediates
10/30/2001CA2048027C 3-arylindole and 3-arylindazole derivatives
10/25/2001WO2001079262A1 Pyrazinone and pyridinone derivatives as thrombin inhibitors
10/25/2001WO2001079198A1 Pyrazoles for inhibiting protein kinase
10/25/2001WO2001079195A2 Pyridine and pyrazine derivatives as thrombin inhibitors
10/25/2001WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/25/2001WO2001079185A1 Novel amino carboxy alkyl derivatives of barbituric acid
10/25/2001WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
10/25/2001WO2001079167A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/25/2001WO2001078723A1 Compounds and methods
10/25/2001WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
10/25/2001WO2001019798A3 Inhibitors of factor xa
10/25/2001US20010034444 Treating schizophrenia, depression, and Parkinson's disease; side effect reduction
10/25/2001US20010034351 A quinazoline compound
10/25/2001US20010034343 Crohn's diseas, antiulcer agents, asthma, emesis
10/25/2001CA2406475A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/25/2001CA2406396A1 Novel amino carboxy alkyl derivatives of barbituric acid
10/25/2001CA2398446A1 Pyrazoles for inhibiting protein kinases
10/24/2001EP1148053A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
10/24/2001EP1147104A1 Aromatic heterocyclic compounds as antiinflammatory agents
10/24/2001EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/24/2001EP1147094A1 Non-peptide glp-1 agonists
10/24/2001EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents
10/24/2001EP1147092A1 Substituted imidazoles, their preparation and use
10/24/2001EP1147090A1 Novel cationic oxidation bases, their use for dyeing keratin fibres, dyeing compositions and dyeing methods
10/24/2001EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity
10/24/2001EP1147088A1 6-arylphenanthridines with pde-iv inhibiting activity
10/24/2001EP1147083A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
10/24/2001EP1146877A1 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
10/24/2001EP1045843A4 Inhibitors of farnesyl-protein transferase
10/24/2001EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/24/2001EP0840733B1 A triazolylmethyl-indole ethylamine bisulfate salt
10/24/2001EP0835246B1 Aromatic compounds and pharmaceutical compositions containing them
10/24/2001CN1319095A Imidazole compounds and their use as adenosine deaminase inhibitors
10/24/2001CN1319094A Imidazolyl derivatives
10/24/2001CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001CN1319090A Novel substuted indolimones, their preparation process and use as medicine
10/23/2001US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/23/2001US6307056 Inhibit or modulate protein kinases, in particular jnk protein kinases.
10/23/2001US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001US6306883 Compounds
10/23/2001US6306865 Pharmaceutically active benzoquinazoline compounds
10/23/2001US6306859 Piperidine alkyl imides as neurotransmitters
10/23/2001US6306181 For dyeing human hair
10/23/2001CA2087606C (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
10/23/2001CA2054143C Salicylic acid derivatives
10/23/2001CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
10/18/2001WO2001077650A1 Analyte detection & apparatus therefor
10/18/2001WO2001077102A1 Macrocyclic chelants for metallopharmaceuticals
10/18/2001WO2001077085A1 Quinazoline compounds
10/18/2001WO2001077080A2 Pyrazole compounds having anti proliferative activity
10/18/2001WO2001077075A2 Inhibitors of inflammation and reperfusion injury
10/18/2001WO2001027087A3 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils
10/18/2001WO2001025213B1 Pyrrolo imidazole derivatives and their use as medicaments
10/18/2001US20010031780 Compounds such as (s,s)1-(2-amino-3,3-dimethyl-butyryl)-2,5-dihydro-1h-pyrrole-2 -carbonitrile administered as antidiabetic agents; dipeptidyl peptidase-iv (dpp-iv)
10/18/2001US20010031754 Method for treating ocular pain
10/18/2001DE10016893A1 Substituierte Phenyluracile Substituted Phenyluracils
10/18/2001CA2403365A1 Quinazoline compounds
10/18/2001CA2306170A1 Novel amino, carboxy derivatives of barbituric acid
10/17/2001EP1144405A1 Triazole compounds with dopamine-d3-receptor affinity
10/17/2001EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors
10/17/2001EP1144390A2 Kinase inhibitors
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1143959A2 Antifungal activity of dicationic molecules
10/17/2001EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
10/17/2001EP1143916A2 Topical compositions comprising protected functional thiols
10/17/2001EP1143796A1 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
10/17/2001EP0652871B1 Benzodiazepine derivatives
10/17/2001CN1318052A Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers
10/17/2001CN1317966A Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treating troubles mediated by excess of substance P
10/17/2001CN1317965A Compounds having IgE affecting properties
10/17/2001CN1073089C Benzodizaepine derivtive, its compsns. and use of preparing medicines
10/16/2001US6303793 Intermediates for cyclin-dependent kinase inhibitors
10/16/2001US6303783 1- (3-Heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents
10/16/2001US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative
10/16/2001US6303628 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents
10/16/2001US6303615 2,3 disubstituded-4(3H)-quinazolinones
1 ... 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 ... 626